Indian Sirolimus Exporters: Complete Supplier Ranking with Market Share — 128 Manufacturers (2026) — TransData Nexus

Q: Who is the largest sirolimus buyer importing from India?

EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) is the largest sirolimus importer from India with a 48.1% market share and import value of $7.2M.

Q: How many sirolimus buyers import from India?

There are 128 active sirolimus buyers importing from India, with a combined import market of $14.9M across 1,244 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top sirolimus buyers from India?

The top 5 sirolimus buyers — EVERSANA LIFE SCIENCE SERVICES, ASCEND LABORATORIES,LLC, DR REDDYS LABORATORIES INC, ASCEND LABORATORIES LLC, XX RXXDYSXXABOXXTORXXS IXX — together control 88.6% of total sirolimus import value from India.

Suresh Sormare

Sirolimus

India Pharmaceutical Trade Intelligence

$14.9M97 Suppliers48 CountriesHS 30049099

ExportsIndia → UNITED STATES97.5%India → VENEZUELA0.5%

ImportsUNITED STATES → India$67.2K BRAZIL → India$49.9K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $14.5M through 116 shipments. This represents a market share of 97.5% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• EVERSANA LIFE SCIENCE SERVICES - $7.2M (49.4% of country's total business)

• ASCEND LABORATORIES,LLC - $3.6M (24.8% of country's total business)

• DR REDDYS LABORATORIES INC - $1.2M (8.6% of country's total business)

• ASCEND LABORATORIES LLC - $646.6K (4.5% of country's total business)

• XX RXXDYSXXABOXXTORXXS IXX - $540.8K (3.7% of country's total business)

• Rest of United States's importers - $1.3M (9.1% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $125.2K, indicating premium pricing strategy compared to the market average of $12.0K.

United States is a key market for Sirolimus imports, representing 97.5% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Sirolimus buyer market intelligence

1Buyer Segment Analysis

The 128 buyers of Sirolimus from India can be categorized into several segments:

1. Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES and ASCEND LABORATORIES, LLC, which account for significant portions of the total export value ($7.17M and $3.60M respectively), function as intermediaries. They procure Sirolimus in bulk and distribute it to healthcare providers, pharmacies, and other end-users. Their purchasing patterns typically involve large, regular orders to maintain a steady supply chain.

2. Contract Manufacturers: Companies such as DR. REDDY'S LABORATORIES INC. ($1.25M) and GLENMARK PHARMACEUTICALS INC. ($0.16M) likely import Sirolimus for further processing or formulation into finished pharmaceutical products. Their procurement is characterized by bulk purchases aligned with production schedules and market demand forecasts.

3. Hospital Groups and Clinical Services: Entities like SMALL ANIMAL CLINICAL SERVICES ($0.18M) may represent specialized healthcare providers or veterinary clinics that import Sirolimus directly for patient treatment. Their buying behavior is typically demand-driven, with orders placed as needed to meet patient requirements.

The repeat buyer rate of 60.9% indicates a stable demand and ongoing relationships between Indian exporters and these buyers, suggesting consistent quality and reliability in the supply chain.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Sirolimus buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Sirolimus from India, the import regulations are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Sirolimus is approved by the FDA. This involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions.

Estimated Timeline for Registration: The FDA review process for NDAs typically takes 10 months, while ANDAs may take 8-10 months.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the U.S.

2. Venezuela:

Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel (INHRR).

Import Registration Process: Importers must obtain a Sanitary Registration from INHRR, which requires submission of product dossiers, including quality, safety, and efficacy data.

Demand Drivers & Market Opportunity

TransData Nexus Sirolimus buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Sirolimus in importing countries is driven by several factors:

1. Disease Prevalence: Sirolimus is primarily used as an immunosuppressant in organ transplantation. The increasing incidence of organ transplants globally fuels demand. For instance, in the United States, over 42,800 organ transplants were reported in 2022, indicating a substantial patient base requiring immunosuppressive therapy.

2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding healthcare access, leading to increased availability of essential medicines. Programs aimed at universal health coverage ensure that critical drugs like Sirolimus are accessible to a broader population, thereby driving demand.

3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Sirolimus is included in the World Health Organization's Essential Medicines List, guiding countries in prioritizing procurement. Many governments and international organizations conduct tender-based purchasing to acquire essential medicines, ensuring a steady demand for Sirolimus.

With 128 buyers across 48 countries, the market for Sirolimus imported from India demonstrates a diverse and sustained demand, influenced by these global health initiatives and the critical role of Sirolimus in transplant medicine.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Sirolimus Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest sirolimus buyer importing from India?

Based on import volume and value, EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with $7.2M in imports and a 48.1% market share — the highest of any single sirolimus importer. ASCEND LABORATORIES,LLC (UNITED STATES) and DR REDDYS LABORATORIES INC (UNITED STATES) are the next largest buyers.

QHow many companies buy sirolimus from India?

There are 128 active sirolimus buyers importing from India, with a combined market of $14.9M across 1,244 shipments to 48 countries. The top 5 buyers hold 88.6% of total import value, while the remaining 123 buyers handle the other 11.4%.

QWhich countries import the most sirolimus from India?

The top importing countries for sirolimus from India are United States (97.5%), Venezuela (0.5%), Switzerland (0.4%), Ireland (0.4%), Chile (0.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of sirolimus, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for sirolimus from India?

The average import transaction value for sirolimus from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Sirolimus buyer market intelligence

1Buyer Segment Analysis

The 128 buyers of Sirolimus from India can be categorized into several segments:

The repeat buyer rate of 60.9% indicates a stable demand and ongoing relationships between Indian exporters and these buyers, suggesting consistent quality and reliability in the supply chain.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Sirolimus buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Sirolimus from India, the import regulations are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Estimated Timeline for Registration: The FDA review process for NDAs typically takes 10 months, while ANDAs may take 8-10 months.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the U.S.

2. Venezuela:

Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel (INHRR).

Import Registration Process: Importers must obtain a Sanitary Registration from INHRR, which requires submission of product dossiers, including quality, safety, and efficacy data.

Demand Drivers & Market Opportunity

TransData Nexus Sirolimus buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Sirolimus in importing countries is driven by several factors:

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Sirolimus

Sirolimus

Who Buys Sirolimus from India — 128 Importers Behind a $14.9M Market

Top Sirolimus Importers — Ranked by Import Value

Top Sirolimus Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Sirolimus — and from which countries?

Sirolimus — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Sirolimus Buyers & Importers

QWho is the largest sirolimus buyer importing from India?

QHow many companies buy sirolimus from India?

QWhich countries import the most sirolimus from India?

QWhat is the average import order value for sirolimus from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Venezuela

3Switzerland

4Ireland

5Chile

Analysis Methodology